Genpact Limited
G
$48.04
$0.220.46%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.77B | 4.66B | 4.59B | 4.52B | 4.48B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.77B | 4.66B | 4.59B | 4.52B | 4.48B |
| Cost of Revenue | 3.08B | 3.01B | 2.97B | 2.92B | 2.91B |
| Gross Profit | 1.69B | 1.65B | 1.62B | 1.60B | 1.57B |
| SG&A Expenses | 970.21M | 958.13M | 944.55M | 934.33M | 915.78M |
| Depreciation & Amortization | 26.48M | 27.43M | 28.44M | 30.14M | 31.46M |
| Other Operating Expenses | -4.12M | -4.11M | -4.18M | -4.20M | -526.00K |
| Total Operating Expenses | 4.07B | 3.99B | 3.94B | 3.88B | 3.85B |
| Operating Income | 697.50M | 670.40M | 654.44M | 636.64M | 623.95M |
| Income Before Tax | 676.82M | 652.75M | 632.16M | 620.12M | 602.22M |
| Income Tax Expenses | 163.15M | -10.32M | -15.68M | -21.98M | -29.03M |
| Earnings from Continuing Operations | 513.67 | 663.06 | 647.84 | 642.10 | 631.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 513.67M | 663.06M | 647.84M | 642.10M | 631.26M |
| EBIT | 697.50M | 670.40M | 654.44M | 636.64M | 623.95M |
| EBITDA | 791.65M | 765.87M | 751.02M | 735.55M | 725.51M |
| EPS Basic | 2.88 | 3.68 | 3.59 | 3.54 | 3.47 |
| Normalized Basic EPS | 2.37 | 2.27 | 2.18 | 2.11 | 2.05 |
| EPS Diluted | 2.84 | 3.64 | 3.54 | 3.50 | 3.43 |
| Normalized Diluted EPS | 2.34 | 2.24 | 2.16 | 2.09 | 2.02 |
| Average Basic Shares Outstanding | 713.54M | 718.62M | 722.42M | 726.00M | 729.38M |
| Average Diluted Shares Outstanding | 721.75M | 725.92M | 730.01M | 734.92M | 740.57M |
| Dividend Per Share | 0.61 | 0.60 | 0.58 | 0.57 | 0.55 |
| Payout Ratio | 21.12% | 16.07% | 16.14% | 15.92% | 15.84% |